Copyright ©The Author(s) 2020.
World J Meta-Anal. Apr 28, 2020; 8(2): 54-66
Published online Apr 28, 2020. doi: 10.13105/wjma.v8.i2.54
Table 2 Clinical activity of probiotics in inflammatory bowel disease
ProbioticClinical activity in IBDRef.
Escherichia coli Nissle 1917Induction and maintenance of UC remission[16,57,58,62]
VSL#3Induction and maintenance of UC remission; prevention of relapses in chronic pouchitis[65,66,68,69]
Saccharomyces boulardiiClinical remission of UC[68-70]
Bifidobacterium longumObjective improvements in UC parameters[71]
Lactobacillus acidophilus La-5 + Bifidobacterium BB-12Probable improvement of intestinal parameters in IBD[72]